INTRODUCTION
Interest in polyamine catabolism has increased since its role in determining cellular sensitivity to various antitumour polyamine analogues has been acknowledged [1, 2] . Until recently, the mammalian polyamine catabolic pathway was thought to consist of two enzymes, namely a rate-limiting spermidine\spermine N"-acetyltransferase (SSAT) [3] and a polyamine oxidase (PAO) that preferentially catalyses the oxidation of the N"-acetylpolyamines produced by SSAT activity. This oxidation results in the production of H # O # , 3-acetamidopropanal, and putrescine or spermidine (Spd), depending on the starting substrate [4] . H # O # production by increased polyamine catabolism in response to specific polyamine analogues has been shown to result in cytotoxicity by these agents in specific tumour-cell types, and this cytotoxicity can be attenuated through the use of a specific inhibitor [5] . However, studies into the role of polyamine oxidation in mammalian cells have been limited by the lack of any verified mammalian PAO clones. Our recent cloning of the human PAO gene PAOh1 provided the first mammalian PAO clone for study and demonstrated the ability of the gene product to catalyse spermine (Spm) oxidation [6] . By using alternative methods, another group of workers have recently confirmed PAOh1 activity and have shown that, in their system, this enzyme shows a greater specificity for the native polyamine, Spm, as a substrate [7] . These data suggest that this oxidase represents an additional enzyme in polyamine catabolism that preferentially utilizes the polyamines as substrates.
The potential importance of PAOs in anticancer drug response is underscored by the finding that PAO is significantly inducible by antitumour polyamine analogues in a manner similar to SSAT [6] , suggesting that its activity may play a direct role in cell death via toxic H # O # production. Additionally, polyamine oxidation has recently been identified as a critical step in the detoxification of one of the antitumour polyamine analogues, and tumour cells that have low to non-detectable levels of polyamine oxidation capacity are significantly more sensitive to the cytotoxic effects of the analogue [8] .
Here we report the discovery that the human PAOh1 gene codes for at least four active isoenzymes that result from alternative splicing of eight exons. The resultant proteins have different biochemical characteristics and substrate specificities, and were identified in a variety of tumour and normal cell types. Because of the potential for cell-or tissue-specific PAO isoenzyme expression levels, the products of the PAOh1 gene may contribute in unique ways to our understanding of polyamine metabolism and antitumour-drug-sensitivity.
EXPERIMENTAL PAO splice variant cloning
PAO isoforms were isolated using reverse-transcription (RT-) PCR on total RNA from NCI-H157 non-small-cell lung carcinoma (NSCLC) cells and HEK-293 cells. A human placenta cDNA library was also used as a source for potential splice variants, as previously described [6] . PCR products were ligated into the pCR2.1 vector (Invitrogen, Carlsbad, CA, U.S.A.), sequenced using a PerkinElmer ABI automated DNA sequencer, and analysed by comparison with the previously identified human genomic PAO sequence located in GenBank2 (accession no. AL121675). Novel sequences corresponding to alternative splicing were further cloned into the pcDNA3.1 j\kmammalian expression vectors using restriction-enzyme digestion and ligation, and proper insertion was confirmed via restriction analysis. These constructs were designated pPAOh2, pPAOh3, and pPAOh4. All restriction and modification enzymes were purchased from Invitrogen or New England Biolabs (Beverly, MA, U.S.A.).
In vitro transcription and translation
For PAO splice variant protein analysis, each cDNA construct, as well as the pcDNA3.1 empty vector, was linearized using NdeI. In itro transcription and translation was subsequently performed using the Wheat Germ Extract-TT coupled system from Promega (Madison, WI, U.S.A.) according to the manufacturer's protocol. Reactions were performed in parallel, with one aliquot containing [$&S]methionine in the amino acid mixture for subsequent separation and quantification by SDS\PAGE. Labelled reaction products were run on 10 %-(w\v)-BisTris gels (Invitrogen) with 20 mM Mops buffer, pH 7.7, as suggested by the manufacturer. After drying, bands were visualized and quantified using phosphorimage analysis with Image Quant software from Molecular Dynamics (Sunnyvale, CA, U.S.A.).
PAO enzyme activity analysis
TT products from the reactions using unlabelled substrates were used for PAO enzyme analysis by the method of Suzuki et al [9] . Specifically, 10 µl of the TT reaction mixture was used for each 600 µl of PAO assay sample (in duplicate, and in the presence of monoamine and diamine oxidase inhibitors, as previously described [6] ). Background oxidase activity in the Wheat Germ Extract-TT reactions was determined for each substrate using the empty pcDNA3.1 vector. These values (always 0.05 pmol\min) were subtracted from the oxidase activity measured in TT lysates produced from vectors containing the individual splice variants. To ensure linearity of the reaction (thereby determining the optimal incubation time after substrate addition), time courses were performed for each potential isoenzyme in the presence of 1 mM Spm (Sigma, St. Louis, MO, U.S.A.).
Kinetics of PAO isoenzymes
Apparent kinetics were examined for each isoenzyme using TT reaction products as described above with increasing concentrations of Spm, Spd (Sigma) or N"-acetylspermine (N"-AcSpm; Fluka). Apparent K m and V max values were determined using the Lineweaver-Burk transformation of the Michaelis-Menten equation. Values were adjusted for TT reaction efficiency by SDS\PAGE quantification of a [$&S]methionine-labelled aliquot of the TT reaction mixture normalized for methionine content.
Specific activities of PAO isoforms
Specific activities were determined for each isoform with each substrate at 0.25 mM. Specific activity was calculated on the basis of band intensity resulting from parallel TT reactions in the presence of [$&S]methionine and normalized according to number of methionine residues present in the splice-variant protein sequences. One unit of PAO activity was defined as the ability to produce 1 pmol of H # O # \min per unit of protein (where 1 unit of protein corresponds to one band intensity unit, as determined from PhosphorImager analysis).
RESULTS
Upon sequence comparison with our previously identified PAO isoform 1 (GenBank2 accession no. AY033889), as well as with the human genomic PAO sequence (GenBank2 accession no. AL121675), we confirmed the isolation of three additional splice variants, designated PAOh2, PAOh3 and PAOh4. Isoforms 1 and 2 were isolated using the cDNA of a human placental library. PAOh2 was also isolated from the H157 NSCLC cell line, as was PAOh3, which was also obtained from HEK-293 mRNA. PAOh4 was obtained only from HEK-293 mRNA. It should be noted that exon V of PAOh1 possesses an internal region that can act as an intron, and which is spliced out of exon V of both PAOh2 and PAOh4, resulting in two smaller exons, designated exons Va and Vb. Also, PAOh4 contains an additional exon, VIa, which is not present in the other three isoforms. PAOh3 is completely devoid of exons IV-VIa, and possesses an open reading frame of only 190 amino acids, which is less than half that of the other three splice variants ( Figures 1A and 1B) . Surprisingly, many of the amino acids missing from PAOh3 correspond to those implicated in FAD cofactor binding in Zea mays (maize) PAO [10, 11] .
Since the stabilities of the various isoforms could differ, it was first necessary to determine the appropriate assay times for each splice variant to ensure measurements were made within the linear range. Time-course data using 1 mM Spm as substrate revealed a linear production of H # O # by all isoforms for approximately 20 min (results not shown). Therefore 10 min was chosen as the period of incubation following substrate addition for further experiments.
Relative kinetic analysis performed with TT reaction products revealed distinct kinetic parameters and substrate affinities for each splice variant with Spm, Spd and N"-AcSpm (Figure 2 ). Apparent K m and V max values for each isoform with each substrate were calculated from the Lineweaver-Burk transformation, and are presented in Figure 2(A) . Importantly, PAOh4 demonstrated the lowest K m values for each of the substrates (in the nanomolar range), and appeared to have the highest affinity for Spd. In contrast, PAOh1 and PAOh2 had relatively low affinities for the acetylated polyamine (in the high micromolar range). The shortest of the four isoforms, PAOh3, also demonstrated a greater affinity for Spd and Spm than for N"-AcSpm.
Using saturating concentrations of each substrate as apparent from Figure 2 (0.25 mM), PAO activity assays were carried out using TT-produced protein that was translated in parallel with an aliquot in the presence of [$&S]methionine. This enabled a comparison of specific activities among the splice variants based on the number of methionine residues present in the each splice variant (Figure 3) . Normalization for methionine content revealed that the shortest isoform, PAOh3, possessed the highest specific activities for all three substrates. Consistent with the predicted K m and V max values, Spd and N"-AcSpm activities were slightly higher than that of Spm. PAOh1 possessed the next highest activities for all substrates, followed by PAOh2 and PAOh4, which demonstrated similar activities, in spite of the much lower K m values predicted for PAOh4 (Figure 3) .
Figure 3 Specific activities of PAO isoforms with various polyamine substrates
Protein produced from parallel TNT reactions in the presence and absence of [ 35 S]methionine was used for PAO activity analysis (A) or quantified by SDS/PAGE (B). Band intensities in (B) were normalized for the methionine content of each isoform and used for determination of specific activity values in (A).
DISCUSSION
The catabolism of polyamines has been demonstrated to be associated with the response of specific tumour types to several antitumour polyamine analogues [5, 12] . Further, alterations in the enzymes that control polyamine catabolism have been implicated in the progression of neoplastic disease [13] . The mechanisms underlying these observations appear to be associated with oxidation of polyamines concurrent with the induction of SSAT. The results presented here demonstrate that each of the four identified splice variants from the PAOh1 gene are capable of catalysing the oxidation of multiple substrates, including Spd, Spm and N"-AcSpm, suggesting that multiple oxidases coded by a single gene may significantly affect polyamine homoeostasis and potential drug response. These results are in contrast with those reported by Vujcic et al. [7] , who did not obtain evidence of oxidation of any substrate other than Spm following transfection of cells with a construct homologous with PAOh1. The reasons for this variation may be a result of differences in reaction conditions. Specifically, the enzyme analyses presented here were performed in borate buffer at pH 9.0. The analyses by Vujcic et al. [7] were performed in glycine buffer at pH 9.5. Consistent with their results, when glycine buffer was substituted for borate buffer in the system used here, only Spm was efficiently catalysed by any of the splice variants (results not shown). Another potential basis for the difference in the observations presented here from those of Vujcic et al. [7] may result from the use of a plant system (wheat-germ TT) to produce our protein. This is necessary, since the mammalian rabbit reticulocyte system contains haem iron that would prevent the precise measurement of H # O # produced [6] . The production of protein in the wheatgerm TT may result in alternate substrate specificity based on potential differences in protein folding or a difference in cofactors or post-translational modifications between the wheat-germ system and those occurring in the transfected-cell system [14] . These results are, however, consistent with observations with the PAOs of the maize and barley (Hordeum ulgare) plants, which are nearly identical in size with the human PAOh1 protein, and which possess a protein domain organization very similar to that of the human protein. Both plant proteins are able to use both Spm and Spd as substrates [15, 16] . Although the validation of substrate specificity awaits the availability of purified proteins representing the individual splice variants, the important finding that each of the splice variants codes for active proteins with different kinetic behaviour is both valid and significant.
It should be noted that Vujcic et al. [7] also provided data on two constructs that were referred to as ' splice variants ' (GenBank2 accession nos. AK025938 and BC000669), neither of which produced oxidase activity in transfected cells. BC000669 corresponds to our PAOh2 (GenBank2 accession no. AY033890) with the exception of one amino acid at position 16. AK025938 possesses an open reading frame that codes for a polypeptide of 389 amino acids that does not correspond to any of the splice variants presented here. However, the open reading frame starts at an AUG codon corresponding to a region within exon 4 of PAOh1, and the original clone has no leader sequence associated with it. Consequently, the possibility that this cDNA represents a cloning artifact rather than an actual splice variant must be considered. More importantly, no data are provided to confirm that the transfected cells actually produce any protein from the constructs. Consequently, the studies indicating the lack of PAO activity in cells transfected with these sequences is currently difficult to interpret.
It is clear from our present results that the multiple splice variants are capable of catalysing multiple polyamine substrates in the system as reported. Interestingly, the shortest splice variant, PAOh3, appears to have the highest k cat of all the isoforms, and was the most common variant to be detected by the RT-PCRbased cloning strategy used. It was isolated from the H157 and HEK-293 cells presented here, as well as in subsequent studies using normal human lymphocytes, and from DU145 prostate cancer cells. This prevalence of PAOh3 is quite possibly the result of higher cloning efficiency of the shorter sequence, but the significance that the existence of this isoform does not appear to be cell-or tissue-type-specific should not be overlooked. The K m values in the micromolar range exhibited by PAOh3, as well as by PAOh1 and PAOh2, for the native polyamines is certainly within the intracellular concentration ranges often predicted, although the free intracellular polyamine concentration is difficult to estimate. PAOh4 exhibits K m values in the nanomolar range for Spd, Spm and N"-AcSpm. This result may be significant, since the amount of acetylated polyamines in the cell is generally low, even with a high induction of SSAT activity. However, the ability of N"-AcSpm to act as a substrate for PAOh4 in situ would depend on the concentration of free Spm and Spd, since they, too, are high-affinity substrates for PAOh4. It should be noted that PAOh4 was only obtained from the human embryonal kidney cell line.
It is not clear that any of the isoenzymes studied here is homologous with the animal PAO reported in the literature prior to our cloning of PAOh1 [4, 13] . That PAO has been defined as a peroxisomal enzyme [17, 18] . None of the isoenzymes presented here possesses a recognizable peroxisomal signal localization sequence [19] . Consequently, it is possible, as suggested by Vujcic et al. [7] , that the isoenzymes coded for by the multiple splice variants of the PAOh1 gene represent an entirely new family of oxidases.
The results presented here demonstrate that the human PAO gene PAOh1 codes for multiple isoforms with significant activities that are capable of using multiple polyamine substrates within physiologically relevant K m values. The relative expression of these various isoforms within the cell and among various cells is currently being investigated. The possibility that the various PAO isoforms may have a direct role in polyamine homoeostasis and, more importantly, in drug response to various antitumour polyamine analogues, underscores the critical importance of gaining a better understanding of this interesting group of enzymes.
